View clinical trials related to LAAO With Amplatzer Amulet.
Filter by:The objectives of the current proposal are to analyse to what extend: 1. The use of 3D in silico simulation by FEops HEARTguide improves of influences the pre-procedural assessment and device size selection and to what extend it correlates with final implanted device size and depth compared to TEE, CT and angiography. 2. The use of 3D in silico simulation by FEops HEARTguide increases the operator's confidence in the device size selection. A total of 100 consecutive patients for the total registry, or 15 to 20 consecutive patients per center, with standard of care follow-up at ±6 weeks and 1 year post procedure.